Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This a pilot study to evaluate the efficacy and safety of Tacrolimus Sustained-release
Capsules (ADVAGRAF) treatment for the induction therapy of refractory lupus nephritis (LN).